Recent reports suggested that melanoma-associated antigen D2 (MAGED2) is a novel regulator of NKCC2, a gene identified by whole-exome sequencing in families affected by transient antennal Bartter’s syndrome with polyhydramnios (Laghmani et al., 2016). This evidence concerns the gene MAGED2 and Bartter syndrome.